ANI
20 May 2022, 12:25 GMT+10
Mumbai (Maharashtra) [India], May 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States FoodDrug Administration (US FDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytigareg;1 Tablets, 500 mg, of Janssen Biotech Inc.
According to IQVIAtrade;sales data for the 12-month period ending March 2022, the Zytigareg;Tablets, 500 mg market2 achieved annual sales of approximately USD 260.2 million.
Glenmark's current portfolio consists of 173 products authorized for distribution in the US marketplace and 49 ANDA's pending approval with the US FDA.
In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.
Glenmark Pharmaceuticals Ltd (Glenmark) is a global innovation-driven pharmaceutical company with presence across specialty, generics and OTC businesses.
Globally, Glenmark focuses on the following key therapy areas: respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across four continents and operations in over 80 countries.
It was ranked among the world's top 50 Generics and Biosimilars companies (Top 50 Company Rankings, 2020, from Informa's Generics Bulletin). The company has been listed on the Dow Jones Sustainability Index (DJSI), under the category of emerging markets for the fourth consecutive year in a row, most recently in 2021.
DJSI is one of the world's most respected and widely accepted sustainability benchmarks globally with only the top ranked companies in terms of Corporate Sustainability within each industry are featured in the index.
References:1) All brand names and trademarks are the property of their respective owners2) Market includes brand and all available therapeutic equivalentsIQVIAtrade;National Sales Perspectives: RetailNon-Retail, March 2022This story is provided by PRNewswire. ANI will not be responsible in any way for the content of this article. (ANI/PRNewswire)Get a daily dose of International Travel News news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to International Travel News.
More InformationLONDON, U.K.: Physically backed gold exchange-traded funds recorded their most significant semi-annual inflow since the first half...
AMSTERDAM, Netherlands: Some 32 percent of global semiconductor production could face climate change-related copper supply disruptions...
NEW YORK, New York - U.S. stocks rebounded Tuesday with all the major indices gaining ground. Markets in the UK, Europe and Canada...
NEW YORK CITY, New York: Financial markets kicked off the week on a cautious note as President Donald Trump rolled out a fresh round...
RIO DE JANEIRO, Brazil: At a two-day summit over the weekend, the BRICS bloc of emerging economies issued a joint declaration condemning...
LONDON, U.K.: This week, BP appointed Simon Henry, former Shell finance chief, to its board as a non-executive director effective September...
WASHINGTON, D.C.: Travelers at U.S. airports will no longer need to remove their shoes during security screenings, Department of Homeland...
PARIS, France: A strike by French air traffic controllers demanding improved working conditions caused significant disruptions during...
New Delhi [India], July 11 (ANI): A special 'Swarnim Bharat Yatra' tourist train under the Bharat Gaurav scheme will depart on August...
Kolkata (West Bengal) [India], July 10 (ANI): Jammu and Kashmir Chief Minister Omar Abdullah on Thursday said that the responsibility...
Kolkata (West Bengal) [India], July 10 (ANI): Jammu and Kashmir Chief Minister Omar Abdullah on Thursday said that he stands firmly...
AJMAN, 10th July, 2025 (WAM) -- The Ajman Department of Tourism Development (ADTD) has honoured the winners of the Tourism Innovator...